Get Our FREE Newsletter

Sign Up

bluebird (BLUE) Filing for Thalassemia Therapy Gets Priority Review

Spread the love

bluebird bio, Inc. BLUE recently announced that the FDA has accepted the biologics license application (BLA) for betibeglogene autotemcel (beti-cel) for priority review.

This post was originally published on this site